81
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

, , , , , , & show all
Pages 2739-2748 | Published online: 16 Oct 2018

References

  • IbrahimLDiazgranadosNFranco-ChavesJCourse of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyNeuropsychopharmacology20123761526153322298121
  • DallaspeziaSBenedettiFChronobiological therapy for mood disordersExpert Rev Neurother201111796197021721914
  • EichhammerPKharrazAWiegandRSleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulationLife Sci200270151741174912002519
  • KreuzerPMLangguthBSchecklmannMEichhammerPHajakGLandgrebeMCan repetitive transcranial magnetic stimulation prolong the antidepressant effects of sleep deprivation?Brain Stimul20125214114722037130
  • SzubaMPBaxterLRAltshulerLLLithium sustains the acute antidepressant effects of sleep deprivation: preliminary findings from a controlled studyPsychiatry Res19945132832958208874
  • DiazgranadosNIbrahimLBrutscheNEA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionArch Gen Psychiatry201067879380220679587
  • BenedettiFColomboCSleep deprivation in mood disordersNeuropsychobiology201164314115121811084
  • BergerMVollmannJHohagenFSleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patientsAm J Psychiatry199715468708729167521
  • BeckJHemmeterUBrandSMuheimFHatzingerMHolsboer-TrachslerEModafinil reduces microsleep during partial sleep deprivation in depressed patientsJ Psychiatr Res2010441385386420171656
  • HemmeterUHatzingerMBrandSHolsboer-TrachslerEEffect of flumazenil-augmentation on microsleep and mood in depressed patients during partial sleep deprivationJ Psychiatr Res2007411087688416978648
  • BenedettiFDallaspeziaSLorenziCGene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivationJ Affect Disord2012136351451922119086
  • GieseMBeckJBrandSFast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivationJ Psychiatr Res2014591725258340
  • HaileCNMurroughJWIosifescuDVPlasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depressionInt J Neuropsychopharmacol201417233133624103211
  • LajeGLallyNMathewsDBrain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patientsBiol Psychiatry20127211e27e2822771240
  • BachmannVKleinCBodenmannSThe BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificitySleep201235333534422379239
  • CoyleCMLawsKRThe use of ketamine as an antidepressant: a systematic review and meta-analysisHum Psychopharmacol201530315216325847818
  • KishimotoTChawlaJMHagiKSingle-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectoriesPsychol Med20164671459147226867988
  • ZarateCABrutscheNEIbrahimLReplication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trialBiol Psychiatry2012711193994622297150
  • ZarateCASinghJBCarlsonPJA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depressionArch Gen Psychiatry200663885686416894061
  • MurroughJWIosifescuDVChangLCAntidepressant efficacy of ketamine in treatment-resistant major depression: a two-site random-ized controlled trialAm J Psychiatry2013170101134114223982301
  • DumanRSAghajanianGKSynaptic dysfunction in depression: potential therapeutic targetsScience20123386103687223042884
  • Machado-VieiraRIbrahimLHenterIDZarateCANovel glutamatergic agents for major depressive disorder and bipolar disorderPharmacol Biochem Behav2012100467868721971560
  • MaengSZarateCAThe role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effectsCurr Psychiatry Rep20079646747418221626
  • DuncanWCSarassoSFerrarelliFConcomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorderInt J Neuropsychopharmacol201316230131122676966
  • BunneyBGBunneyWERapid-acting antidepressant strategies: mechanisms of actionInt J Neuropsychopharmacol201215569571321733282
  • BelletMMVawterMPBunneyBGBunneyWESassone-CorsiPKetamine influences CLOCK:BMAL1 function leading to altered circadian gene expressionPLoS One201168e2398221887357
  • Ancoli-IsraelSColeRAlessiCChambersMMoorcroftWPollakCPThe role of actigraphy in the study of sleep and circadian rhythmsSleep200326334239212749557
  • TeicherMHActigraphy and motion analysis: new tools for psychiatryHarv Rev Psychiatry19953118359384925
  • DuncanWCSlonenaEHejaziNSMotor-Activity Markers of Circadian Timekeeping Are Related to Ketamine’s Rapid Antidepressant PropertiesBiol Psychiatry201782536136928457485
  • BenloucifSGuicoMJReidKJWolfeLFL’Hermite-BalériauxMZeePCStability of melatonin and temperature as circadian phase markers and their relation to sleep times in humansJ Biol Rhythms200520217818815834114
  • SackeimHAThe definition and meaning of treatment-resistant depressionJ Clin Psychiatry200162Suppl 161017
  • DuncanWCSelterJBrutscheNSarassoSZarateCABaseline delta sleep ratio predicts acute ketamine mood response in major depressive disorderJ Affect Disord2013145111511922871531
  • McclungCACircadian rhythms and mood regulation: insights from pre-clinical modelsEur Neuropsychopharmacol201121Suppl 4S683S69321835596
  • BurtonCMckinstryBSzentagotai TătarASerrano-BlancoAPagliariCWoltersMActivity monitoring in patients with depression: a systematic reviewJ Affect Disord20131451212822868056
  • NaismithSLLagopoulosJHermensDFDelayed circadian phase is linked to glutamatergic functions in young people with affective disorders: a proton magnetic resonance spectroscopy studyBMC Psychiatry201414134525496061
  • BaehrEKRevelleWEastmanCIIndividual differences in the phase and amplitude of the human circadian temperature rhythm: with an emphasis on morningness-eveningnessJ Sleep Res20009211712710849238
  • ReidKJJaksaAAEisengartJBSystematic evaluation of Axis-I DSM diagnoses in delayed sleep phase disorder and evening-type circadian preferenceSleep Med20121391171117722910327
  • KasperSHajakGWulffKEfficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertralineJ Clin Psychiatry201071210912020193645
  • RaouxNBenoitODantchevNCircadian pattern of motor activity in major depressed patients undergoing antidepressant therapy: relationship between actigraphic measures and clinical coursePsychiatry Res199452185988047624
  • WinklerDPjrekEPraschak-RiederNActigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapyBiol Psychiatry200558433133616102546
  • BenedettiFDallaspeziaSFulgosiMCBarbiniBColomboCSmeraldiEPhase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depressionChronobiol Int200724592193717994346
  • LewyAJLeflerBJEmensJSBauerVKThe circadian basis of winter depressionProc Natl Acad Sci U S A2006103197414741916648247
  • WehrTAWirz-JusticeAGoodwinFKDuncanWGillinJCPhase advance of the circadian sleep-wake cycle as an antidepressantScience19792064419710713227056
  • Wirz-JusticeAChronobiology and mood disordersDialogues Clin Neurosci20035431532522033593
  • SorecaICircadian rhythms and sleep in bipolar disorder: implications for pathophysiology and treatmentCurr Opin Psychiatry201427646747125211500
  • VitaternaMHKoCHChangAMThe mouse Clock mutation reduces circadian pacemaker amplitude and enhances efficacy of resetting stimuli and phase-response curve amplitudeProc Natl Acad Sci U S A2006103249327933216754844
  • HamppGAlbrechtUThe circadian clock and mood-related behaviorCommun Integr Biol2008111319704445
  • HarveyAGSleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulationAm J Psychiatry2008165782082918519522
  • MilhietVEtainBBoudebesseCBellivierFCircadian biomarkers, circadian genes and bipolar disordersJ Physiol Paris20111054–618318921767641
  • RoybalKTheoboldDGrahamAMania-like behavior induced by disruption of CLOCKProc Natl Acad Sci U S A2007104156406641117379666
  • SchnellAAlbrechtUSandrelliFRhythm and mood: relationships between the circadian clock and mood-related behaviorBehav Neurosci2014128332634324660658
  • PartonenTClock gene variants in mood and anxiety disordersJ Neural Transm2012119101133114522538398
  • AllebrandtKVTeder-LavingMAkyolMCLOCK gene variants associate with sleep duration in two independent populationsBiol Psychiatry201067111040104720149345
  • NovákováMSládekMSumováAHuman chronotype is determined in bodily cells under real-life conditionsChronobiol Int201330460761723445508
  • AschoffJPohlHPhase relations between a circadian rhythm and its zeitgeber within the range of entrainmentNaturwissenschaften19786528084345129
  • ErzbergerAHamppGGranadaAEAlbrechtUHerzelHGenetic redundancy strengthens the circadian clock leading to a narrow entrainment rangeJ R Soc Interface20131084221
  • DijkDJDuffyJFSilvaEJShanahanTLBoivinDBCzeislerCAAmplitude reduction and phase shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure in humansPLoS One201272e3003722363414
  • UedaHRHayashiSChenWSystem-level identification of transcriptional circuits underlying mammalian circadian clocksNat Genet200537218719215665827